MyOnyx System
510(k) K213197Ref SA9020
Active
Valid until
No date given
FDA recalls
None found
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/MDD EUDAMED | NumberB-07540191000593 07540191000593 | Date20 May 2026 | StatusActive |
| United States | GUDID listing GUDID | Number07540191000593 | Date7 Jun 2023 | StatusListed |
| United States | FDA 510(k)SESE 510(k) | NumberK213197 | Date17 Jun 2022 | StatusActive |
| United States | FDA 510(k)SESE GUDID | NumberK201014 | Date13 Jan 2021 | StatusActive |
Official records
- EUDAMED public site B-07540191000593
- AccessGUDID record 07540191000593
- FDA 510(k) database K213197
- FDA 510(k) database K201014
Across registries
- EUDAMED Basic UDI-DI B-07540191000593 registered 20 May 2026 Active
- FDA 510(k) K213197 decided 17 Jun 2022 Active
- FDA GUDID UDI-DI 07540191000593 listed 7 Jun 2023 Listed
Timeline
- Cleared FDA 510(k) K201014
- Cleared FDA 510(k) K213197
- Listed FDA GUDID 07540191000593
- Registered EUDAMED B-07540191000593
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- Trade name
- MyOnyx
- Generic name
- Psychophysiological biofeedback system
- Model / reference
- SA9020
- FDA applicant
- Thought Technology , Ltd.
- Primary DI / UDI-DI
- 07540191000593
- Basic UDI-DI
- B-07540191000593
- FDA product code
- IPF, KPI, HCC, GZJ
- EMDN code
- N01028099, U070399, Z12062401, Z12062899
- GMDN term
- Psychophysiological biofeedback system
- Device class
- Class IIa EUDAMEDClass II 510(k)GUDID
- Regulation
- 21 CFR Part 890.5850 510(k)GUDID876.5320 GUDID882.5050 GUDID882.5890 GUDID
- EU registration type
- Legacy device (under a directive)
- EU market of registration
- France
- Advisory committee
- Physical Medicine
- FDA decision
- SESE Substantially Equivalent
- GUDID distribution status
- In Commercial Distribution
Truth per registry
| Field | EUDAMED | 510(k) | GUDID |
|---|---|---|---|
| Device class | Class IIa | Class II | Class II |
Overview
AI-generated summary, 18 Sep 2026
The MyOnyx System is a powered muscle stimulation device classified as an electrical stimulator, non-implantable. It is designed to address muscle spasms, facilitate muscle re-education, prevent or slow disuse atrophy, improve range of motion, enhance local blood circulation, and reduce post-surgical venous thrombosis risk through targeted calf muscle stimulation.
The device is supplied as a reusable system and is intended for clinical use in physical medicine settings. It operates under FDA 510(k) clearance (K213197) and complies with the Medical Device Directive (MDD). No specific sterility or MRI safety information is provided in the available data, and no single-use designation is indicated.
Devices cleared under K213197
Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.
| UDI-DI | Size and differences | |||
|---|---|---|---|---|
| MyOnyx Mobile App SA9030 | SA9030 | 07540191000586 | — | On the market |
| MyOnyx SA9020 | SA9020 | 07540191000593 | — | On the market |
Similar devices in this category
Other devices filed under NEUROLOGIC PHYSIOTHERAPHY DEVICES.
- ManovoSpring 29568 by HOCOMA AG
- ArmeoPower 30806 by HOCOMA AG
- MyOnyx Mobile App SA9030 by Thought Technology Ltd.
- Electrotherapy equipment - pad P-75 by Elektronika i Elektromedycyna M.Lewandowski Sp.J.
- Little PALS SEN 5001 by AXELGAARD MANUFACTURING CO., LTD.
- CEFALY 11302 by Cefaly Technology
- Wandy Self-adhesive Electrodes P4-50x50mm-T by Wandy Rubber Industrial Co., Ltd
- Cefaly® CEFALY DUAL Enhanced 10601 by Cefaly Technology SPRL
- Dr. Senst AS1080 by Shenzhen AsTec Technology Co., Ltd
- Digital Tens dual channel BE-92660 by BESMED HEALTH BUSINESS CORP.